A randomized, open label, single dose, crossover, bioequivalence study of Dimethyl Fumarate 240mg capsule of Nanoalvand Co., IRAN in comparison of Tecfidera 240mg capsule of Biogen in 24 healthy adult subjects under fasting condition

anoalvand Co.0 个研究点目标入组 48 人开始时间: 待定最近更新: 2021年7月12日

适应症

试验速览

暂无简介。

•Aged between 18 - 50 years
•- Body weight between 50 – 100 kg
•- Having good health on the basis of medical history and physical & clinical examination
•- Understand the procedures and give written informed consent

•Subject had undergone surgery of the gastro-intestinal tract treatment.
•Subject had donated a unit of blood or participated in another clinical trial, within the last two months before the first
•Subject had a history of drug or alcohol abuse.
•Subject who smokes more than 10 cigarettes per day.
•Subject had used any prescription medication within 14 days, or any non-prescription medication within 7 days, before the first treatment.

发起方

anoalvand Co.